A challenge at the FDA: Getting new generics to market

Nov 17, 2015
Right now, it takes a long time to bring a generic drug to market — 48 months.

Problems in the U.S. drug pipeline

Feb 10, 2014
Ahead of the release of a GAO report and a Congressional hearing Monday on drug shortages, we look at what’s behind the increasing number of problems in the U.S. drug pipeline (quality control and closed plants are two reasons) and play out how the shortages affect the cost of delivering care and patients’ health.